Similarly, our study revealed that Salvigenin lessened glucose uptake and lactate generation, lowered the levels of HK2, PFK1, and PKM2, and abated 5-FU-resistant HCC cells’ resistance to 5-FU. This evidence concerns the gene HK2 and hepatocellular carcinoma.